Study finds prediabetes remission possible without weight loss

New research published in Nature Medicine reveals that people with prediabetes can normalize blood sugar levels without losing weight. About one in four participants in lifestyle programs achieved this remission, offering protection against diabetes similar to weight loss methods. The key factors involve fat distribution and certain hormones.

For decades, advice for those with prediabetes—a condition affecting up to one in three adults, depending on age—has centered on weight loss to prevent diabetes. Yet diabetes rates continue to rise globally, and many struggle to meet weight targets. A study challenges this by showing prediabetes remission without weight reduction is feasible and equally protective against type 2 diabetes. In the research, published in Nature Medicine (2025; 31(10):3330, DOI: 10.1038/s41591-025-03944-9), approximately one in four individuals in lifestyle interventions normalized blood sugar without shedding pounds, and sometimes even with weight gain. The explanation lies in fat storage. Visceral fat, deep in the abdomen around organs, drives inflammation and impairs insulin function, raising blood glucose. Subcutaneous fat under the skin, however, aids metabolism by releasing supportive hormones. Participants achieving remission shifted fat from visceral to subcutaneous areas. Hormones also play a role, particularly GLP-1-like ones, which enhance insulin release from pancreatic beta cells when glucose rises. Those in remission boosted these naturally while curbing glucose-raising hormones—similar to effects from drugs like Wegovy and Mounjaro. Practical steps include diets rich in polyunsaturated fatty acids, such as Mediterranean-style with fish oil, olives, and nuts, which reduce visceral fat. Endurance exercise similarly targets abdominal fat without necessitating overall weight drop. While weight loss remains beneficial for health, the study urges prioritizing blood sugar normalization and metabolic shifts. Authors from University of Tübingen, including Andreas L. Birkenfeld and Reiner Jumpertz-von Schwartzenberg, suggest doctors track these changes for patients facing weight loss difficulties. This approach could broaden diabetes prevention worldwide.

ተያያዥ ጽሁፎች

Pediatrician assessing overweight children in clinic, highlighting study-recommended early treatment to prevent adult risks like diabetes and hypertension.
በ AI የተሰራ ምስል

Study recommends treatment for all children with obesity

በAI የተዘገበ በ AI የተሰራ ምስል

A new Karolinska Institutet study finds that children with moderate obesity face higher risks of type 2 diabetes, high blood pressure, and lipid disorders in adulthood, even without apparent risk markers. Researchers urge treatment for all such children.

A year-long observational study in Japan suggests that people with type 2 diabetes who tend to overeat in response to tempting food cues such as sight and smell may see greater weight loss—and possibly better blood-sugar improvement—after starting GLP-1 receptor agonists, while those with primarily emotional eating patterns show less consistent links to long-term outcomes.

በAI የተዘገበ

A low-fat vegan diet has shown promise in helping people with type 1 diabetes cut their daily insulin needs by nearly 30%, according to new research. The study, published in BMC Nutrition, found that participants on this plant-based plan also saved on insulin costs without restricting calories or carbohydrates. In contrast, those following a portion-controlled diet saw no significant changes.

A new study shows that a high-fat ketogenic diet can normalize blood sugar levels in mice with hyperglycemia and enhance their muscles' response to exercise. Led by researcher Sarah Lessard, the research indicates that combining the diet with physical activity leads to better oxygen use and endurance. The findings suggest potential benefits for metabolic health when diet and exercise are paired.

በAI የተዘገበ

New research shows that visceral fat around the waist increases heart failure risk more than BMI, even among those with normal weight. Inflammation mediates much of this link. The findings were presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026 in Boston.

A team led by Leonardo Ferreira at the Medical University of South Carolina is developing a novel therapy combining lab-made insulin-producing cells with engineered immune cells to protect them. Funded by $1 million from Breakthrough T1D, the approach aims to restore beta cell function without immunosuppressive drugs. This strategy builds on prior research and targets all stages of the disease.

በAI የተዘገበ

New research from Turkey shows that men with obesity tend to develop more abdominal fat and liver stress, while women exhibit higher inflammation and cholesterol levels. These findings, presented at the European Congress on Obesity in Istanbul, highlight sex-based differences that could inform personalized treatments. The study analyzed patients treated between 2024 and 2025.

 

 

 

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ